Skip to content
Parakho

Supriya Lifescience Ltd

NSE SUPRIYABSE 543434supriyalifescience.comInvestor relations

Q1 FY27, unaudited

Revenue
₹189.75 Cr
Profit after tax
₹24.04 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations189.75+30.79%827.88
Other income2.65−0.97%11.49
Total income192.40+30.22%839.36
Employee benefit expense28.49+25.57%96.68
Finance costs0.37−26.95%1.89
Depreciation & amortisation8.94+38.58%28.41
Total expenses151.60+51.10%564.13
Profit before tax40.79−13.96%274.78
Tax expense16.75+32.70%65.66
Profit after tax24.04−30.89%209.12
Total comprehensive income24.69−28.59%209.02
Earnings per share
Earnings per share, basic₹2.99₹25.98
Earnings per share, diluted₹2.99₹25.98

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Earnings call

Q4 FY26

Supriya Lifescience reported record quarterly revenue of INR277 crores in Q4 FY26, up 50% year-on-year, with full-year FY26 revenue of INR828 crores, up 18.9%, and EBITDA margin of 35.5%. Management said the Lote facility received a USFDA Establishment Inspection Report with Voluntary Action Indicated classification after a surprise inspection with only one minor observation. Management also discussed new product launches including a cardiovascular intermediate and an ADHD product, and reiterated a target of INR1,000 crores revenue by FY27.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 35 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 22 Aug 2026.